VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

10047	Companies
204817	Keywords
135071	Articles
108593	Press releases

Home
Companies
VALNEVA

BRIEF

published on 08/07/2025 at 07:22, 7 months 10 days ago

Valneva Obtains FDA Lift of Ban on IXCHIQ®

FDA Valneva Chikungunya IXCHIQ® Vaccine Elderly People
PRESS RELEASE

published on 08/07/2025 at 07:17, 7 months 10 days ago

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva announces FDA's removal of recommended pause on Chikungunya Vaccine IXCHIQ® in elderly individuals and updates to the Prescribing Information, following EMA's recommendation. Updates reflect Serious Adverse Events and expanded Warnings and Precaution section

FDA Valneva Chikungunya Vaccine Prescribing Information Vaccine Updates
BRIEF

published on 07/28/2025 at 13:51, 7 months 20 days ago

Valneva SE: Positive Outlook Amid Chikungunya Concerns

Biotech Valneva SE Equity Research Chikungunya Vaccine Market
PRESS RELEASE

published on 07/28/2025 at 13:46, 7 months 20 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Valneva SE (FR0004056851) rating to Buy with a target price of €8.10 amidst global Chikungunya outbreak warning by WHO

First Berlin Equity Research BUY Rating Valneva SE Chikungunya Outbreak EUR 8.10 Target Price
BRIEF

published on 06/26/2025 at 07:05, 8 months 21 days ago

Valneva Secures Exclusive Vaccine Distribution in Germany with CSL Seqirus

Valneva Germany Market 2025 Sales Growth CSL Seqirus Vaccine Distribution
PRESS RELEASE

published on 06/26/2025 at 07:00, 8 months 21 days ago

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus
Valneva SE announces exclusive vaccine marketing and distribution agreement for Germany with CSL Seqirus. CSL to commercialize Valneva's vaccines IXCHIQ®, IXIARO®, and DUKORAL®

Distribution Agreement Germany Valneva SE CSL Seqirus Vaccine Marketing
BRIEF

published on 06/25/2025 at 17:50, 8 months 22 days ago

Valneva General Meeting Approves Key Resolutions

Financial Guidance Annual Meeting Valneva Board Appointments Vaccine Company
PRESS RELEASE

published on 06/25/2025 at 17:45, 8 months 22 days ago

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
Valneva SE announces successful outcome of its Annual General Meeting approving 2024 financial statements and appointing Dr. Gerd Zettlmeissl to the Board. Confirms FY 2025 guidance. Shares held steady on Nasdaq & Euronext Paris

Annual General Meeting Financial Guidance Valneva SE Vaccine Company Dr. Gerd Zettlmeissl
BRIEF

published on 06/05/2025 at 07:35, 9 months 12 days ago

Valneva: Share and Voting Rights Statement - May 2025

Common Shares Euronext Paris Voting Rights Capital Increase Valneva
PRESS RELEASE

published on 06/05/2025 at 07:30, 9 months 12 days ago

[Valneva SE] Declaration of shares and voting rights - May 2025
Valneva declares changes in shares and voting rights including double voting rights on ordinary shares and capital increase without preferential subscription rights

Voting Rights Shares Capital Increase Valneva Double Voting Rights

Accesswire

Published on 03/17/2026 at 21:30, 25 minutes ago

Rainy Mountain Announces Appointment of Colton Griffith to Board of Directors
Published on 03/17/2026 at 21:10, 45 minutes ago

BTU Announces Financing
Published on 03/17/2026 at 13:30, 8 hours 25 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 8 hours 25 minutes ago

Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 8 hours 55 minutes ago

Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland

View all ACCESSWIRE

EQS Group

Published on 03/17/2026 at 21:21, 34 minutes ago

KION GROUP AG successfully places a bond of € 500 million
Published on 03/17/2026 at 20:55, 1 hour ago

EQS-Adhoc: thyssenkrupp nucera lowers its sales and EBIT outlook for the Group and the gH2 segment for FY 2025/26 due to higher project costs
Published on 03/17/2026 at 18:07, 3 hours 48 minutes ago

POS-Transaction in Own Shares
Published on 03/17/2026 at 17:58, 3 hours 57 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 17:45, 4 hours 10 minutes ago

FIGEAC AÉRO: THREE NEW WINS IN MEXICO

Les Echos

Published on 03/17/2026 at 07:00, 14 hours 55 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 3 hours ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 3 hours ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 3 hours ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 1 day 4 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE